1 – 10 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study
- Contribution to journal › Article
-
Mark
The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis – results from 14 European countries
- Contribution to journal › Article
-
Mark
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
- Contribution to journal › Scientific review
-
Mark
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased
- Contribution to journal › Article
-
Mark
Musculoskeletal diseases, infections and vaccines : state of the art, research perspectives and educational needs
- Contribution to journal › Scientific review
-
Mark
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
- Contribution to journal › Article
-
Mark
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis : results from nine European registries
- Contribution to journal › Article
-
Mark
Biological material for biomarker research in spondyloarthritis : mapping the availability in European rheumatology registries
- Contribution to journal › Letter
-
Mark
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden
- Contribution to journal › Article
-
Mark
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors : a nationwide direct drug-to-drug comparison
- Contribution to journal › Article